NHS figures have revealed that the number of people in England being taken into hospital for serious mental health problems have soared due to taking drugs. The number has doubled in a 10 year period, with statistics recording the damaging effects that illicit drugs such as cannabis and cocaine have had on people’s mental health.
In 2016 – 2017 hospitals in England treated 82,135 people for drug abuse, a 115% increase on the 38,170 people treated in 2006 – 2007. According to a recent report by The Guardian, the number of people admitted to hospital under the age of 16 has nearly doubled from 402 to 799, whilst those aged 16 to 24 has risen dramatically from 6,983 to 12,369 (77%).
MDMA has been named as the key factor behind the growing number of people being treated in hospital. Former legal highs such as mephedrone and Spice have also been named as likely explanations for the rise. Chair of the addictions faculty at the Royal College of Psychiatrists, Professor Colin Drummond has said that the increase is extremely concerning and mirrors the growing number of hospital admissions due to alcohol.
With heroin and morphine related deaths now at their highest following the 2017 record number, it has become evident that the problem needs to be addressed.
As part of our unrivalled toxicology test menu, Randox Toxicology’s DoA ULTRA panel detects up to 20 targeted drugs, offering the largest cross-reactivity profile of over 240 analytes including opiates; morphine and heroin. As the number one supplier of New Psychoactive Substance tests our NPS I panel detects the latest designer drugs on the market. Using our revolutionary Biochip Array Technology, Randox Toxicology provide cutting-edge multiplex testing capabilities for rapid and accurate drug detection from a single sample.
For more information about our DoA ULTRA and NPS I panels, email firstname.lastname@example.org or visit www.randoxtoxicology.com